New Hope for Lowering the Risk of Dementia
Just this week, I was asked by a colleague to comment on a fairly technical article, and I was struck by the exact wording used in its opening question: Are cardioprotective glucose-lowering agents associated with reduced risk of dementia? I spend a fair bit of time reviewing and replying to questions and requests from our […]
Breakthrough Study Links GLP-1 to Reduced Alcohol Dependence
Researchers have been exploring whether glucagon-like peptide-1 receptor (GLP-1) agonists, such as semaglutide and liraglutide, could help treat alcohol use disorder (AUD). A long-term study with over 8 years of follow-up found that people using these drugs had a significantly lower risk of hospitalization for AUD compared to those on officially approved AUD treatments. This […]
The Truth: Diet and Exercise Vs. Obesity Medication
If there’s still some doubt in your mind about whether you can lose more weight with a simple diet and exercise program than you can with the highly popular new weight-loss medicines, then you should pay some attention to the following quote that puts this issue to rest once and for all. According to Dr. […]
Are Your Kidneys OK?
The human body can manage with reduced kidney function for a long time, often without showing any signs. This is why World Kidney Day 2025’s theme is, Are Your Kidneys OK? Detect early and protect kidney health. While chronic kidney disease has no cure, if it is caught early enough, measures can be taken to […]
News: Zepbound (tirzepatide) Approved to Treat Obstructive Sleep Apnea
The weight-loss drug Zepbound is the first FDA-approved prescription medicine to help treat obstructive sleep apnea (OSA). Zepbound, or tirzepatide, originally received approval in November 2023 to treat obesity. It’s now a new rival to Novo Nordisk’s popular drug, Wegovy. The FDA has now given the green light for tirzepatide to treat obstructive sleep apnea […]
Improve GLP-1 Weight Loss With Healthy Weight Pack
The weight loss effects of glucagon-like peptide-1 (GLP-1) medications like Wegovy are well known. In studies, patients taking a 2.4-mg dose of semaglutide, the active ingredient in Wegovy, lost about 6% of their body weight in 12 weeks and 12% in 28 weeks. Combining targeted ingredients like those provided by the Healthy Weight Pack with GLP-1 can […]
Semaglutide Has Done it Again for Knee Osteoarthritis
Drug trials involving human test subjects always involve some level of dropout. Dropout refers to how many subjects stopped participating before the planned end date – for any reason. In most instances, the level of dropout has negative connotations because it means that the subjects were either experiencing intolerable side effects or were not sticking […]
Bye Bye BMI?
As we approach Healthy Weight Week in January, I recently went back over our published material relating to the subject of weight. This was both from the perspective of how many conditions can be triggered by the fact that people are no longer eating well and also, on the brighter side, that thanks to the […]
Using Nutrition to Offset GLP-1 Side Effects
Glucagon-like peptide-1 (GLP-1) drugs like Ozempic and Wegovy are among the latest innovations in diabetes and weight management. However, they do come with some commonly experienced side effects for users. Happily, I can advise about some nutritional changes that can work to reduce these side effects while also enhancing the efficacy of the medications. GLP-1 […]
The Battle for Rights to Sell Weight Loss Drugs
If you have been using the popular diabetes and weight-loss drugs Ozempic/Wegovy and Mounjaro/Zepbound, take note! You could be affected by the fight that’s looming between BigPharm and the Compounding Pharmacies over the latter continuing to supply look-alike versions of these drugs. Right now, the FDA appears to be backed into a corner. It has […]
